Register now for a personalized educational experience.
Already a member? Log In
By linking my Doximity account with UPMC Physician Resources, I acknowledge that:
Forgot your password? Enter the email address you used to create your account to initiate a password reset.
Dr. Mark Roberts provides an overview of Hepatitis C and the new direct acting antivirals, a primer on cost effectiveness analysis (CEA) in health care, using models to predict the impact of new treatment on the Hepatitis C epidemic, and purpose: to use the new drugs for hepatitis C as a vehicle to understand cost effectiveness.
Upon completion of this activity, participants should be able to:
Dr. Roberts has reported no relevant relationships with any entities producing health care goods or services.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to .75 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 5/10/2014 | Last Modified On: 5/10/2014 | Expires: 5/9/2015